Certolizumab inhibits radiographic progression in patients with early rheumatoid arthritis and high rheumatoid factor levels: A pooled, post-hoc analysis of the phase 3 C-EARLY and C-OPERA trials

This publication has 39 references indexed in Scilit:

• Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study
  Rheumatology International, 2022
• 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
  Arthritis Care & Research, 2021
• Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort
  Immunological Medicine, 2021
• Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis
  Modern Rheumatology, 2018
• Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
  Bone Research, 2018
• Pathogenetic insights from the treatment of rheumatoid arthritis
  The Lancet, 2017
• Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients
  Clinical Rheumatology, 2014
• Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components
  Arthritis & Rheumatism, 2006
• The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysis
  Arthritis & Rheumatism, 2004
• Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
  Arthritis & Rheumatism, 1998